RE:sound familiarAnd also familiar...
AXIM has 0 revenue...51 million shares oustanding....but yet valued at $434 million US market cap....
LDS is extremely undervalued. Peer comparisons are rational and relevant. Whether the stock price is rational or not is irrelevant. If AXIM is being valued at $434 million based on potential, then LDS should be given that same treatment.
julia7777777777 wrote: AXIM Biotechnologies Inc. has made a name for itself by creating unique delivery systems for cannabinoids
The advancements that Dr. Sanderson has achieved will allow LDS to significantly differentiate the CannaStrips technology from any other delivery method currently available for any product worldwide." The company intends to incorporate these new innovations into the current product line in the first quarter of 2017.
Major diffference axim 20cents to 8.44 as of yesterday in 6 weeks
lds 80 to roughly 80 cents in 6 weeks
conclusion...the latter is extremely undervalued in my opinion....